New hope: immune drug may let some bladder cancer patients avoid bladder removal
Disease control
Ongoing
This study tests whether the immunotherapy drug pembrolizumab can shrink muscle-invasive bladder cancer enough to allow some patients to keep their bladder. About 46 adults with localized cancer will receive pembrolizumab, then be rechecked. If the cancer is gone or nearly gone, …
Phase: PHASE2 • Sponsor: Matthew Galsky • Aim: Disease control
Last updated May 15, 2026 11:53 UTC